How big is the Medical Devices Market?

The Medical Devices Market is valued at US$ 600.93 Billion in 2025, it is projected to reach US$ 1091.64 Billion by 2033.

What is the CAGR for Medical Devices Market by (2026 - 2033)?

As per our report Medical Devices Market, the market size is valued at US$ 600.93 Billion in 2025, projecting it to reach US$ 1091.64 Billion by 2033. This translates to a CAGR of approximately 7.75% during the forecast period.

What segments are covered in this report?

The Medical Devices Market report typically cover these key segments- Type (Orthopedic Devices, Cardiovascular Devices, Diagnostic Imaging Devices, In-vitro Diagnostics , Minimally Invasive Surgery Devices, Wound Management, Diabetes Care Devices, Ophthalmic Devices, Dental Devices, Nephrology Devices, General Surgery, Others) End-User (Hospitals & ASCs, Clinics, Others)

What is the historic period, base year, and forecast period taken for Medical Devices Market?

The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Medical Devices Market report: 2022-2024 2025 2026-2033

Who are the major players in Medical Devices Market?

The Medical Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include: Medtronic plc ; Johnson & Johnson ; Koninklijke Philips N.V. ; F. Hoffmann-La Roche Ltd ; Boston Scientific Corporation ; Fresenius Medical Care AG ; GE HealthCare Technologies Inc. ; Siemens Healthineers AG ; Stryker Corporation ; Abbott Laboratories ; Becton, Dickinson and Company

Who should buy this report?

The Medical Devices Market report is valuable for diverse stakeholders, including: Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns. Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies. Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry. Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies. Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market. Essentially, anyone involved in or considering involvement in the Medical Devices Market value chain can benefit from the information contained in a comprehensive market report.

Medical Devices Market Outlook: Size, Share, Trends, Growth Analysis, Competitive Landscape & Forecast, 2026-2033

The Medical Devices Market size was valued at US$ 600.93 Billion in 2025 and is projected to reach US$ 1091.64 Billion by 2033, growing at a CAGR of 7.75% during 2026–2033, driven by aging populations, chronic disease management, minimally invasive procedures, AI-enabled diagnostics, connected monitoring, and healthcare infrastructure investment.

Report Coverage

Type: Orthopedic Devices, Cardiovascular Devices, Diagnostic Imaging Devices, In-vitro Diagnostics , Minimally Invasive Surgery Devices, Wound Management, Diabetes Care Devices, Ophthalmic Devices, Dental Devices, Nephrology Devices, General Surgery, Others
End-User: Hospitals & ASCs, Clinics, Others

US$ 600.93 Bn Market size in 2025

US$ 1091.64 Bn Market Size by 2033

7.75% CAGR, 2026 - 2033

2026-2033 Forecast Period

Download Sample PDF Buy Now

Format: PDF + Excel + PPT

No. of Pages: 350

Industry: Life Sciences

Report Code: BMIPUB00038835

Last Updated: 2026-09-22

Author

Krishna Sunthwal

Analyst Connect

AI Overview

Medical Devices Market Summary

North America Region: North America holds market share of 38%–41% in 2025, growing with a CAGR of 6.8%–7.4%, supported by reimbursement depth, advanced hospitals, clinical research, robotics, imaging, and rapid regulatory commercialization. The US remains the dominant market, with strong outpatient procedures, cardiovascular intervention, imaging demand, and digital diagnostics supporting a 6.8%–7.3% CAGR through 2033.
Fastest Growing Region: Asia Pacific holds market share of 26%–29% in 2025, growing with a CAGR of 8.2%–9.1%, supported by hospital modernization, local manufacturing, expanding insurance coverage, aging populations, rising diagnostic intensity, and increasing demand for cardiovascular, orthopedic, renal, and surgical technologies.
Leading Segment: In-vitro Diagnostics (IVD) holds market share of 14%–17% in 2025, growing with a CAGR of 7.0%–7.8%, supported by preventive screening, molecular diagnostics, decentralized testing, laboratory automation, personalized medicine, and demand for faster clinical decision-making across healthcare systems.
High Growth Segment: Nephrology Devices holds market share of 4%–6% in 2025, growing with a CAGR of 8.0%–9.5%, supported by kidney disease burden, dialysis expansion, home-based treatment, vascular access innovation, portable technologies, and improving renal-care infrastructure across developing economies.
Key Market Opportunity: Manufacturers can capture additional value by combining hardware, software, AI, remote monitoring, clinical evidence, training, and lifecycle services into integrated platforms that improve utilization and expand healthcare access.
Major Market Players: Medtronic plc; Johnson & Johnson; Koninklijke Philips N.V.; F. Hoffmann-La Roche Ltd; Boston Scientific Corporation; Fresenius Medical Care AG; GE HealthCare Technologies Inc.; Siemens Healthineers AG; Stryker Corporation; Abbott Laboratories; Becton, Dickinson and Company.

Strategic Insights

Medical Devices Market: Strategic Insights

Medical Devices Market Strategic Framework

Stakeholder View

Key Takeaways

The value chain is moving toward integrated ecosystems involving OEMs, component suppliers, software developers, contract manufacturers, hospitals, distributors, and service providers. Installed-base management, cybersecurity, maintenance, training, and post-market evidence are becoming strategic differentiators.
Higher upside is concentrated in IVD, cardiovascular intervention, minimally invasive surgery, nephrology, diabetes care, and connected monitoring, where procedure growth and recurring consumables can improve lifetime customer value.
Innovation is progressing toward AI-assisted imaging, robotic navigation, smaller implants, advanced biomaterials, remote monitoring, automated laboratory workflows, and software-defined devices capable of controlled lifecycle upgrades.
Asia Pacific presents the strongest expansion opportunity because China, India, Japan, South Korea, and Southeast Asia combine large patient populations with healthcare investment and expanding domestic manufacturing.
Investment and M&A activity increasingly targets specialized procedural technologies, vascular intervention, robotics, diagnostics, and complementary capabilities. Medtronic plc’s 2026 acquisition of Scientia Vascular demonstrates the importance of portfolio expansion in high-value procedural categories.

Geographic Outlook

Medical Devices Market Regional Highlights

North America Medical Devices Market

North America held a 38%–41% Medical Devices Market share in 2025 and is modeled to grow at a 6.8%–7.4% CAGR during 2026–2033. The region benefits from high procedure intensity, sophisticated reimbursement, specialist networks, clinical research, and rapid adoption of advanced technologies. The United States accounts for 84%–87% of regional demand, while Canada provides a smaller established base. Recent external industry estimates place North America around the high-30% range globally, supporting the modeled range used here.

Advanced cardiovascular, orthopedic, imaging, and surgical technologies continue attracting investment because hospitals prioritize clinical precision and operational efficiency.
Outpatient migration is increasing demand for compact imaging, navigation, monitoring, and minimally invasive systems that can operate efficiently outside tertiary hospitals.
AI-enabled products are moving toward regulated commercialization, with FDA guidance emphasizing transparency, lifecycle controls, bias assessment, and documentation.
Diversified sourcing and contract manufacturing are becoming more important as manufacturers manage component availability, tariffs, quality requirements, and regional production resilience.

US Medical Devices Market

The US represented 84%–87% of the North American Medical Devices Market demand in 2025 and is modeled to expand at a 6.8%–7.3% CAGR through 2033. Demand is anchored by advanced clinical capacity, high procedure intensity, established reimbursement mechanisms, and rapid adoption of innovative technologies. Hospitals and ASCs increasingly prioritize equipment that improves utilization and staff productivity. FDA activity surrounding AI-enabled devices is also influencing development strategies by emphasizing lifecycle planning, transparency, safety, effectiveness, and controlled software updates.

Robotic surgery, cardiovascular intervention, advanced imaging, and connected monitoring benefit from specialist demand and increasingly data-driven clinical workflows.
Ambulatory surgery expansion creates opportunities for compact, interoperable technologies designed around faster turnover, efficient staffing, and lower facility complexity.
AI regulation is becoming an important competitive consideration because robust documentation and predetermined change-control strategies can support controlled software improvement.

Europe Medical Devices Market

Europe held a 24%–28% Medical Devices Market share in 2025 and is modeled to grow at a 6.3%–7.1% CAGR through 2033. Germany remains a leading market, supported by engineering capabilities, specialized hospitals, and a strong manufacturing ecosystem. The United Kingdom, France, Italy, and the Netherlands provide substantial demand for diagnostics, imaging, surgery, monitoring, and digital health. Germany is modeled near 6.4%–7.0% CAGR, while the United Kingdom and selected Northern European markets can reach 6.8%–7.5%, supported by outpatient care and digital transformation.

Germany benefits from advanced manufacturing, specialist hospitals, engineering expertise, and demand for high-value imaging and surgical technologies.
The United Kingdom provides opportunities in remote monitoring, diagnostics, and workflow technologies as healthcare providers seek capacity and productivity improvements.
France and Italy remain attractive for hospital modernization, minimally invasive procedures, diagnostic infrastructure, and digital healthcare adoption.
European suppliers increasingly emphasize traceability, cybersecurity, interoperability, clinical evidence, and lifecycle services to meet purchasing and regulatory requirements.

Asia Pacific Medical Devices Market

Asia Pacific held a 26%–29% share in 2025 and is modeled to grow at an 8.2%–9.1% CAGR, making it the fastest-growing major region. China remains the largest market, while Japan, India, South Korea, and Southeast Asia contribute expanding demand. China is modeled near 8.8%–9.6% CAGR, while India can reach 9.0%–10.0%, reflecting infrastructure expansion, local production, increasing diagnostic volumes, and greater access to specialized treatment. The region combines scale with expanding domestic technology capabilities.

China’s domestic innovation agenda supports local production while procurement reforms encourage manufacturers to improve cost efficiency, clinical evidence, and supply-chain competitiveness.
India offers strong opportunities in imaging, diagnostics, cardiovascular care, orthopedics, dialysis, diabetes care, and affordable hospital equipment beyond major metropolitan centers.
Japan and South Korea support premium adoption through aging demographics, advanced infrastructure, robotics, imaging, and high reliability expectations.
Southeast Asia is becoming increasingly attractive as private hospitals expand and cross-border healthcare networks stimulate demand for advanced devices.

Rest of World Medical Devices Market

South and Central America represented approximately 4%–6% of global demand in 2025, while Middle East and Africa represented approximately 2%–3%, placing Rest of World at 6%–8%. South America is modeled at a 6.5%–7.5% CAGR, with Brazil and Mexico leading regional scale. Middle East and Africa are modeled at 6.2%–8.0%, supported by Gulf healthcare investment, private hospital development, diagnostic expansion, and healthcare modernization programs. Price sensitivity and distributor dependence remain important commercial considerations.

Brazil offers the strongest Latin American scale, with demand concentrated in cardiovascular care, diagnostics, orthopedic treatment, hospital equipment, and private healthcare networks.
Mexico benefits from proximity to North American supply chains and expanding private-sector healthcare capacity, creating opportunities for localized manufacturing and distribution.
Saudi Arabia and the United Arab Emirates are leading Gulf opportunities as healthcare modernization programs prioritize hospitals, imaging, surgery, and digital care.
African markets remain procurement-sensitive, making durable devices, service networks, financing models, training, and public-sector partnerships essential for sustainable adoption.

Segment Analysis

Medical Devices Market Segmentation

Type

The Type segment covers technologies used for diagnosis, treatment, monitoring, surgery, and chronic care. IVD is modeled at 14%–17% Medical Devices Market share in 2025 and 7.0%–7.8% CAGR through 2034. Adoption depends on disease burden, procedure volumes, clinical evidence, reimbursement, technology intensity, and healthcare infrastructure. Current trends favor integrated instruments, consumables, analytics, software, and lifecycle services that support recurring revenue and clinical workflow optimization.

Orthopedic Devices: Aging, osteoarthritis, trauma, and joint replacement volumes support demand. Robotics, navigation, advanced implants, and patient-specific planning improve procedural precision and recovery.
Cardiovascular Devices: Structural heart, electrophysiology, vascular intervention, pacemakers, and stents benefit from cardiovascular disease prevalence and preference for minimally invasive treatment.
Diagnostic Imaging Devices: CT, MRI, ultrasound, and X-ray systems are advancing through AI reconstruction, automation, improved resolution, and dose-management technologies.
In-vitro Diagnostics (IVD): Molecular testing, immunoassays, pathology, clinical chemistry, and near-patient testing enable earlier diagnosis, screening, monitoring, and personalized treatment decisions.
Minimally Invasive Surgery Devices: Laparoscopic, endoscopic, robotic, energy, visualization, and navigation technologies benefit from shorter recovery objectives and greater procedural precision.
Wound Management: Advanced dressings, negative-pressure therapy, biologics, and pressure-injury solutions address chronic wounds, surgical recovery, and diabetic complications.
Diabetes Care Devices: Glucose monitoring, insulin delivery, connected pens, pumps, and automated systems support continuous disease management and patient engagement.
Ophthalmic Devices: Cataract surgery, intraocular lenses, retinal diagnostics, and refractive technologies benefit from aging populations and expanding eye-care access.
Dental Devices: Imaging, CAD/CAM, implants, restorative systems, and digital workflows are supported by preventive care, cosmetic dentistry, and clinic modernization.
Nephrology Devices: Dialysis machines, consumables, vascular access products, and home-treatment technologies address kidney disease and expanding renal-care capacity.
General Surgery: Surgical instruments, stapling, electrosurgery, visualization, and related technologies support broad procedure volumes across hospitals and ambulatory centers.

End-User

Hospitals & ASCs remain the principal purchasing environment, supported by high procedure volumes, complex care, centralized procurement, and technology modernization. This category is modeled at 65%–70% Medical Devices Market share in 2025 and 7.0%–7.8% CAGR through 2034. Clinics are gaining relevance as healthcare migrates toward outpatient and decentralized settings. Procurement increasingly considers clinical outcomes, interoperability, maintenance, training, utilization, and total cost rather than acquisition price alone.

Hospitals & ASCs: Complex care, high procedure volumes, centralized procurement, and modernization support demand for imaging, surgery, cardiovascular, orthopedic, monitoring, and diagnostic technologies.
Clinics: Specialist practices, diagnostic centers, and outpatient facilities favor compact, connected, easy-to-operate devices with lower installation, staffing, and maintenance requirements.

Market Forces

Medical Devices Market Dynamics

Key Market Drivers

Chronic Disease and Aging-Driven Procedure Demand

Aging populations and chronic diseases are increasing demand for cardiovascular, orthopedic, ophthalmic, diabetes, nephrology, monitoring, and diagnostic technologies. According to WHO, there are roughly 2 million distinct medical devices globally, belonging to over 7,000 generic categories of devices. Growth of market gets bolstered by the increased frequency of disease occurrence which results in repetitive testing, treatment, implantation, and monitoring. Cardiovascular diseases, diabetes, cancers, kidney diseases, and musculoskeletal diseases are some such diseases. Medical Devices Market trends therefore favor platforms that connect diagnosis, treatment, monitoring, and follow-up. The diversity of applications also reduces dependence on one procedure category, improving resilience across changing clinical priorities.

AI, Robotics, and Connected Clinical Workflows

AI applications are evolving from being standalone algorithms to regulated functional aspects of imaging, diagnostics, surgical, monitoring, and workflow technologies. The FDA published its full guidance for AI-enabled medical devices in January 2025 regarding development, documentation, maintenance, transparency, and bias of these devices throughout their total product lifecycle. The FDA has a list of AI-enabled devices that have been authorized for use in the United States. Medical Devices Market growth will be enhanced if AI helps in reducing the need for interpretation, enhances workflow standardization, helps with triaging, and helps with procedural planning. Trends in the market have been moving towards software differentiation, cybersecurity, interoperability, controlled updates, and performance post-marketing. Therefore, software innovation can be transformed into product differentiation.

Minimally Invasive Procedures and Outpatient Migration

Healthcare practitioners are more inclined towards methods that allow for a reduction in the likelihood of admission into the hospital, the recovery period, exposure to complications, and use of facilities. This encompasses cardiovascular catheters, endoscopic devices, robots, energy-based systems, navigation systems, orthopedic systems, and mobile imaging systems. The relocation of some procedures from hospitals to ASCs or clinics has implications for the type of equipment required. This implies that growth in the market is dependent on both the volume of procedures and their changing location. Medical Devices Market trends increasingly reward technologies that improve turnover, standardize workflows, support clinician productivity, and integrate smoothly into distributed care environments.

Key Market Opportunities

Platform-Based Connected Care and Remote Monitoring

Connected devices open up an opportunity of taking care of monitoring patients outside hospital settings but still under clinical supervision. Wearable sensors, diagnostic tests, connected glucose devices, remote cardiac monitoring, and cloud-based patient platforms offer a way of intervening early and decreasing visits to facilities unnecessarily. Such an opportunity exists mainly where the manufacturer ensures validation of measurements, cybersecurity, alerts management, clinical integration and reimbursement options. It may be possible to generate revenue from subscriptions, analytics, maintenance, sensor replacements, and software updates. This opportunity supports Medical Devices Market Forecasts by expanding utilization into longitudinal care and creating additional lifecycle revenue beyond the initial equipment sale.

Emerging-Market Localization and Affordable Innovation

Emerging economies provide an opportunity to redesign products around affordability, serviceability, local procurement, and infrastructure constraints while preserving essential clinical performance. Devices that can work properly in different environments of power, people, connectivity, maintenance, and finances are needed by India, Southeast Asia, Latin America, and Africa. Localization can include manufacturing in the region, local vendors, training for distribution, web-based technical centers, ease of configuration, and knowledge of regulations. The cooperative regulations of the WHO show greater consideration for reliable regulatory bodies and dependence structures, possibly eliminating the need for repeated assessments. Potential opportunities exist for imaging, IVD, dialysis, monitoring, and surgical devices that will create recurring revenue from increased installation bases.

AI-Enabled Diagnostics and Evidence-Led Product Upgrades

AI creates a pathway for upgrading installed imaging, ultrasound, pathology, monitoring, and laboratory systems without replacing complete equipment platforms. Software could help in improving reconstruction, measurements, triage, workflow assistance, quality control, and decision-making, where the changes stay within validated regulatory limits. According to Philips' report in 2026, AI technology had been helping clinicians save their time, and Philips has mentioned the benefits of AI in ultrasound and imaging systems. Thus, this presents an opportunity in algorithm design, clinical data partnerships, workflow integration, and regulatory knowledge. The purchasers are more concerned about the proof showing whether technology has helped increase the efficiency or capability of clinicians.

Market Restraints and Challenges

Regulatory Complexity and Evidence Costs

Factor: Different regulations are applicable to medical devices, which vary from one region to another. New implants, artificial intelligence software, diagnostic systems, and riskier medical products may have to go through long processes of verification before hitting the market.

Impact: This will lead to higher costs for product development, product launches, regulatory processes, and uncertainties in entering the markets, especially for small manufacturers. According to WHO's 2025 report, about 70% of the countries were experiencing difficulties arising from poor regulatory systems. It is possible to eliminate the duplications in terms of regulation through regulatory convergence and dependency, but manufacturers should have effective quality systems and be locally compliant. There is another issue posed by the rapid change of software.

Pricing Pressure, Procurement Fragmentation, and Supply Risk

Factor: Medical practitioners operate under budget restrictions, pressure for payment, centralized purchasing, tariffs, currency fluctuations, and increased focus on total cost of care. The devices require specialized electronics, plastics, metal products, semiconductors, clean room processes, and approved vendors.

Impact: The margin squeeze, capital investment delays, qualification time, and disruptions due to the lack of availability of key components are some of the challenges manufacturers may face. Big health care organizations now look at utilization, training, costs of consumables, outcomes of treatment, as well as the cost of equipment. This risk can be reduced through multiple sourcing, regional production, inventory management, life cycle services approach, and clinical differentiation. This, however, requires capital and operational discipline, favoring manufacturers that are better capitalized and diversified.

Company Analysis

Competitive Landscape

The Medical Devices Market analysis indicates competition is shaped by portfolio breadth, clinical evidence, installed base, regulatory capability, innovation speed, service infrastructure, and strategic acquisitions. Leading companies increasingly combine devices with software, diagnostics, data, training, and lifecycle services.

Company Name	Overview	Products and Services relevant to this market
Medtronic plc	Global medical technology company with broad cardiovascular, neuroscience, diabetes, and surgical exposure.	Cardiac devices, ablation, neurovascular technologies, surgical systems, diabetes technologies, implants, and procedural solutions.
Johnson & Johnson	Diversified healthcare company with major MedTech exposure across surgery, orthopedics, cardiovascular intervention, and vision.	Robotic surgery, electrophysiology, orthopedics, surgical instruments, implants, cardiovascular technologies, and ophthalmic products.
Koninklijke Philips N.V.	Health technology company focused on imaging, monitoring, image-guided therapy, ultrasound, and connected care.	MRI, CT, ultrasound, patient monitoring, image-guided therapy, informatics, and workflow solutions.
F. Hoffmann-La Roche Ltd	Healthcare company combining diagnostics, pathology, molecular testing, and personalized healthcare.	IVD systems, pathology platforms, molecular diagnostics, companion diagnostics, laboratory automation, and digital tools.
Boston Scientific Corporation	Medical device specialist with strong positions in cardiology, endoscopy, urology, and peripheral intervention.	Catheters, stents, electrophysiology, endoscopy, urology, neuromodulation, and peripheral vascular technologies.
Fresenius Medical Care AG	Kidney-care company specializing in dialysis products, services, and renal treatment infrastructure.	Dialysis machines, dialyzers, renal consumables, vascular access solutions, dialysis services, and home-care technologies.
GE HealthCare Technologies Inc.	Global medical technology provider focused on imaging, ultrasound, patient care, and digital healthcare.	CT, MRI, X-ray, ultrasound, patient monitoring, contrast technologies, software, and clinical services.
Siemens Healthineers AG	Medical technology company with strong imaging, diagnostics, cancer care, and minimally invasive therapy capabilities.	CT, MRI, molecular imaging, laboratory diagnostics, angiography, radiation oncology, and image-guided therapy.
Stryker Corporation	Medical technology leader specializing in orthopedics, surgery, neurotechnology, and hospital infrastructure.	Joint implants, surgical robotics, navigation, trauma products, endoscopy, powered instruments, and neurovascular technologies.
Abbott Laboratories	Diversified healthcare company with major cardiovascular, diabetes, diagnostics, and monitoring positions.	Cardiac devices, vascular intervention, glucose monitoring, electrophysiology, structural heart technologies, and diagnostics.
Becton, Dickinson and Company	Medical technology company supplying medication management, diagnostics, vascular access, and infection-prevention technologies.	Syringes, infusion systems, vascular access, medication management, diagnostic instruments, specimen collection, and infection-control products.

Trust & Transparency

Research Methodology

The market analysis combines proprietary research with secondary data from government agencies, company disclosures, regulatory filings, industry databases and expert interviews. Market estimates are validated through data triangulation, cross-market benchmarking and analyst review.

View Full Research Methodology

Questions Answered

Frequently Asked Questions

How should investors evaluate device companies beyond revenue growth?

The Medical Devices Market Report highlights that investors should assess recurring consumables, installed-base utilization, procedure exposure, regulatory durability, service revenue, clinical evidence, R&D productivity, supply resilience, and acquisition discipline to judge durable profitability.

Which emerging-market capability can improve market access?

Localized service and regulatory infrastructure can be as important as product pricing. Local distributors, technical training, spare-parts availability, regional assembly, and regulatory expertise can reduce adoption friction and improve device uptime.

How is AI changing device development?

AI is shifting differentiation toward workflow assistance, image reconstruction, decision support, monitoring, and automation. Developers must address lifecycle validation, transparency, cybersecurity, bias, and controlled software changes alongside clinical performance.

Why are ambulatory surgery centers important for device suppliers?

ASCs require compact, efficient, interoperable technologies that support faster turnover and lower facility complexity. Suppliers adapting products, training, maintenance, and financing to outpatient workflows can expand beyond traditional hospital procurement.

What is the primary commercial shift affecting medical device manufacturers?

Manufacturers are moving from standalone equipment toward integrated platforms combining hardware, software, diagnostics, analytics, services, and recurring consumables. This model improves customer retention and creates additional lifecycle revenue.

Access the Full Medical Devices Market Report

Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.

Download Sample Request Customization